Al-Modawat Specialized Medical Co. (9594.SR) — Cash flow
Operating, investing, and financing cash flow for Al-Modawat Specialized Medical Co. — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 20↑233.9% | 6↓67.3% | 19↑80.3% | 10↑567.4% | -2 | |
| Depreciation & Amortization | 8↑40.9% | 6 | 0.00↓100.0% | 2↑9.4% | 2 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -28↓443.9% | -5↑60.4% | -13↓26.5% | -10↓786.2% | 1 | |
| Accounts Receivable | -28↓1813.9% | 2↑110.2% | -16↓111.6% | -8↓368.0% | 3 | |
| Inventory | -1↓157.0% | -0.46↑72.4% | -2↓144.6% | -0.68↓142.3% | 2 | |
| Accounts Payable | 0.00↑100.0% | -1↓538.2% | 0.23↑115.0% | -2↓10254.3% | -0.01 | |
| Other Working Capital | 2↑137.5% | -5↓204.2% | 5↑2029.3% | -0.26↑91.2% | -3 | |
| Other Non-Cash Items | 3↑33.8% | 2↓68.2% | 8↑265.6% | 2↑97.7% | 1 | |
| Net Cash from Operating Activities | 4↓54.2% | 9↓31.3% | 14↑207.3% | 4↑94.8% | 2 | |
| Operating Cash Flow | 4↓54.2% | 9↓31.3% | 14↑207.3% | 4↑94.8% | 2 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -21↓14.1% | -19 | 0.00↑100.0% | -3↑38.6% | -5 | |
| Capital Expenditure | -21↓15.1% | -19↓374.5% | -4↓40.9% | -3↑38.6% | -5 | |
| Acquisitions | -0.01↓126.8% | 0.03 | 0.00 | 0.00 | 0.00 | |
| Purchases of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales & Maturities of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | -0.03 | 0.00↑100.0% | -4 | 0.00 | 0.00 | |
| Net Cash from Investing Activities | -21↓14.4% | -19↓377.7% | -4↓40.9% | -3↑38.6% | -5 | |
| Financing Activities | ||||||
| Net Debt Issuance | 22↑1277.1% | -2↓417.4% | 0.59↑137.1% | -2↓123.0% | 7 | |
| Long-Term Net Debt Issuance | 22↑1277.1% | -2↓417.4% | 0.59↑137.1% | -2↓123.0% | 7 | |
| Short-Term Net Debt Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Stock Issuance | -0.36↓100.7% | 53 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | -0.36↓100.7% | 53 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 0.00↓100.0% | 53 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | -0.36 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -3↑87.0% | -22↓133.7% | -9 | 0.00 | 0.00 | |
| Common Dividends Paid | -3↑87.0% | -22↓133.7% | -9 | 0.00 | 0.00 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -5↓29.8% | -4↓103.4% | -2↑62.6% | -5 | 0.00 | |
| Net Cash from Financing Activities | 13↓45.8% | 25↑330.3% | -11↓53.8% | -7↓201.8% | 7 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | -4↓123.6% | 15↑1488.5% | -1↑79.2% | -5↓215.9% | 5 | |
| Cash at Beginning of Period | 16↑5636.8% | 0.27↓80.2% | 1↓79.4% | 7↑217.8% | 2 | |
| Cash at End of Period | 12↓23.2% | 16↑5636.8% | 0.27↓80.2% | 1↓79.4% | 7 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | -17↓85.2% | -9↓195.6% | 10↑488.8% | 2↑172.7% | -2 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.